2008
DOI: 10.1038/nrm2514
|View full text |Cite|
|
Sign up to set email alerts
|

Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

Abstract: First described over 80 years ago, ataxia-telangiectasia (A-T) was defined as a clinical entity 50 years ago. Although not encountered by most clinicians, it is a paradigm for cancer predisposition and neurodegenerative disorders and has a central role in our understanding of the DNA-damage response, signal transduction and cell-cycle control. The discovery of the protein A-T mutated (ATM) that is deficient in A-T paved the way for rapid progress on understanding how ATM functions with a host of other proteins… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

8
702
1
18

Year Published

2010
2010
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 816 publications
(729 citation statements)
references
References 114 publications
8
702
1
18
Order By: Relevance
“…Following the exposure to genotoxic agents, the serine/threonine kinase ATM directly and indirectly phosphorylates several substrates in order to orchestrate the cellular DNA-damage response (DDR), activating a signaling cascade which induces DNA repair, cell-cycle checkpoint activation and, eventually, apoptosis or senescence (Lavin, 2008). Interestingly, ATM-deficient cells display an increased sensitivity to genotoxic agents (Meyn et al, 1994;Savitsky et al, 1995;Ku¨hne et al, 2004), and chemical inhibition of ATM induces cellular chemo-and radio-resistance (Sarkaria et al, 1998(Sarkaria et al, , 1999Sarkaria and Eshleman 2001).…”
Section: Introductionmentioning
confidence: 99%
“…Following the exposure to genotoxic agents, the serine/threonine kinase ATM directly and indirectly phosphorylates several substrates in order to orchestrate the cellular DNA-damage response (DDR), activating a signaling cascade which induces DNA repair, cell-cycle checkpoint activation and, eventually, apoptosis or senescence (Lavin, 2008). Interestingly, ATM-deficient cells display an increased sensitivity to genotoxic agents (Meyn et al, 1994;Savitsky et al, 1995;Ku¨hne et al, 2004), and chemical inhibition of ATM induces cellular chemo-and radio-resistance (Sarkaria et al, 1998(Sarkaria et al, , 1999Sarkaria and Eshleman 2001).…”
Section: Introductionmentioning
confidence: 99%
“…In fact, in response to DSB induction, H2AX is phosphorylated at the Ser139 residue (the phosphorylated H2AX protein being named c-H2AX) by members of the phosphoinositide-3-kinase-related protein kinase family [e.g., ataxia-telangiectasia-mutated (ATM) kinase and the DNAdependent kinase (DNA-PK)] (6). The p53 binding protein 1 (53BP1) functions downstream of a c-H2AX-dependent hierarchy of proteins (e.g., the MRN complex, ATM, and the media-tor of DNA-damage checkpoint 1 protein (MDC1)) that collectively establish IRIF at DSB sites (7)(8)(9)(10)(11).…”
Section: Introductionmentioning
confidence: 99%
“…ATM is a serine/threonine kinase which belongs to phosphoinositide 3-kinase (PI3K)-related protein kinase (PIKK) family [6]. ATM plays a pivotal role in cellular and molecular response to DSBs, such as cell cycle checkpoint and DSB repair [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…ATM is a serine/threonine kinase which belongs to phosphoinositide 3-kinase (PI3K)-related protein kinase (PIKK) family [6]. ATM plays a pivotal role in cellular and molecular response to DSBs, such as cell cycle checkpoint and DSB repair [6,7]. In G1 checkpoint, ATM transduces DSB signals to Chk2 and p53 by phosphorylation, and induces transient delay of S phase entry at earlier times and more sustained blockage of S phase entry at later times, respectively [8][9][10].…”
Section: Introductionmentioning
confidence: 99%